Month: April 2021

PERSBERICHT: 20 april 2021, 07:00 CEST Biocartis kondigt US FDA 510(k) indiening aan van zijn Idylla™ MSI TestEerste US FDA Oncologie Assay indiening voor Biocartis Mechelen, België, 20 april 2021 Biocartis Group NV (de ‘Vennootschap’ of ‘Biocartis’), een innovatief bedrijf in de moleculaire diagnostiek (Euronext Brussels: BCART), kondigt vandaag de US FDA 510(k) indiening1 aan van de Idylla™ MSI Test2 voor gebruik als in-vitro diagnostisch hulpmiddel voor de identificatie van ‘microsatellite instability’ (MSI) status bij colorectale (darm)kanker om te helpen bij de differentiatie tussen sporadische colorectale (darm)kanker en mogelijk Lynch-syndroom. MSI is het gevolg van de inactivering van het zogenaamde DNA-mismatch-reparatiesysteem (MMR) van het lichaam, dat normaal spontaan fouten corrigeert die tijdens de DNA-replicatie optreden....

Paris (France), April 20, 2021 – Atos today announced it has reached an agreement to acquire Processia, a Product Lifecycle Management (PLM) system integrator and Dassault Systèmes Global Service Partner, headquartered in Canada. With this acquisition, Atos will enhance its capabilities to support manufacturing companies on their transformation journey and adoption of Industry 4.0 technologies, in line with its industry-specific strategy. Through Processia, Atos will reinforce its PLM and Engineering Solutions franchise, complementing its current offerings of Siemens, PTC and Dassault Systèmes services, and expand the Group’s footprint in North America and in Europe, especially in Belgium, Canada, France, India, the Netherlands, the UK and the US. The digitalization imperative has become a top priority for manufacturers, leading them...

Paris, France, le 20 avril 2021 – Atos annonce aujourd’hui avoir signé un accord en vue d’acquérir Processia, intégrateur canadien de systèmes de gestion du cycle de vie des produits (Product Lifecycle Management – PLM) et partenaire « Services » mondial de Dassault Systèmes. Conformément à sa stratégie sectorielle, cette acquisition va renforcer la capacité d’Atos à accompagner la transformation digitale des entreprises industrielles, accélérant leur entrée dans l’ère de l’Industrie 4.0. Les compétences de Processia viendront enrichir la division « PLM et solutions d’ingénierie » d’Atos, complétant ses offres de services actuelles de technologies Siemens, PTC et Dassault Systèmes. D’autre part, cette transaction permettra à Atos d’étendre sa présence en Amérique du Nord et en Europe, notamment en Belgique, au...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN ANY JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO Pratteln, Switzerland, April 20, 2021 – Santhera Pharmaceuticals (SIX: SANN) announces that so far an aggregate principal value of around CHF 39.6 million, or 66% of its CHF 60 Million Convertible Bonds, have been accepted for exchange under the Exchange Offer announced on March 25, 2021. Bondholders who have not yet accepted the Exchange Offer will be able to do so during the additional acceptance period ending on April 27, 2021, 5:00 p.m. CEST. In parallel to the Exchange Offer, voting on the bondholders’ resolution continues. By Notice of Repurchase Offer dated March 25, 2021 (the Notice), Santhera Pharmaceuticals Holding AG announced an offer to exchange its outstanding CHF 60 million 5% Convertible Bonds due 2022 (the 2017/22...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN ANY JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO Pratteln, Schweiz, 20. April 2021 – Santhera Pharmaceuticals (SIX: SANN) gibt als Zwischenergebnis des am 25. März 2021 veröffentlichten Umtauschangebots bekannt, dass von der CHF 60 Millionen 5%-Wandelanleihe bislang Obligationen im Nennwert von insgesamt rund CHF 39.6 Millionen angedient wurden, was 66% der sich im Umlauf befindenden Wandelanleihe entspricht. Inhaber, die ihre Wandelobligationen noch nicht angedient haben, haben dazu während der Nachfrist bis am 27. April 2021 um 17 Uhr (MESZ) weiterhin die Möglichkeit. Parallel zum Umtauschangebot wird die Abstimmung über den Beschluss der Anleihensgläubiger fortgesetzt. Mit dem Rückkaufsinserat vom 25. März 2021 (das Rückkaufsinserat) veröffentlichte Santhera Pharmaceuticals Holding...

LEXINGTON, Mass., April 20, 2021 (GLOBE NEWSWIRE) — Mimecast Limited (NASDAQ: MIME), a leading email security and cyber resilience company, today announced the publication of its “The State of Email Security” report. The report shows enterprises faced unprecedented cybersecurity risk in 2020 from increasing attack volume, the pandemic-driven digital transformation of work, and generally deficient cyber preparedness and training. The fifth annual “The State of Email Security,” report is based on a global survey of 1,225 information technology and cybersecurity leaders, and supported by Mimecast’s Threat Center data, which screens more than one billion emails per day. Ransomware Looms LargeA full 79% of respondents indicated their companies had experienced a business disruption, financial loss or other setback in 2020 due to a lack...

Mowi ASA (OSE:MOWI): Q1 2021 Trading update Harvest volumes Q1 2021 (1)Farming Norway 75.0 thousand tonnesFarming Scotland 18.5 thousand tonnesFarming Canada 10.5 thousand tonnesFarming Chile 19.5 thousand tonnesFarming Ireland 1.0 thousand tonnesFarming Faroes 1.0 thousand tonnesTotal 125.5 thousand tonnesIn connection with the presentation of the Q4 2020 results, Mowi ASA guided a total harvest volume of 116 thousand tonnes (GWE) for Q1 2021. Note:(1) The harvest volumes are provided in gutted weight equivalents (GWE). The figures include salmonid species only. Additional information Operational EBIT for the Group was approximately EUR 109 million in Q1 2021 (EUR 109 million in Q1 2020). Blended Farming cost per kg harvested was EUR 4.20. Total Operational EBIT per kg through the value chain was approximately...

TORONTO, April 19, 2021 (GLOBE NEWSWIRE) — Sprott Inc. (“Sprott”) (TSX:SII) announces that it has filed an updated early warning report under applicable Canadian securities laws in respect of SRHI Inc. (“SRHI”). On April 16, 2021, SRHI closed a bought deal financing (the “Offering“). In connection with the Offering, SRHI issued a total of 20,930,000 units on a bought deal basis, at an offering price of C$0.55 per unit, which included 2,730,000 units issued pursuant to the exercise of the over-allotment option, in full, for gross proceeds of approximately $11.5 million. Each unit consists of one Class A common share in the capital of SRHI and one common share purchase warrant. Each warrant entitles the holder thereof to purchase one common share at a price of $0.70 for a period of 18 months following the closing of the...

DYNAMIC GROWTH – NEW SALES RECORD IN FIRST QUARTER – ANNUAL TARGET RAISEDSales increase of 12.6% in local currencies Q1 sales of CHF 1,998.6 million (+10.2% in CHF) Negative currency effect of –2.4% Acquisition of Kreps (Russia), DriTac (USA), and BR Massa (Brazil) Outlook for 2021 fiscal yearDouble-digit sales growth in local currencies (previously: local currency growth of 6%–8%) Over-proportional increase in EBIT, EBIT margin to reach 15% for the first timeConfirmation of 2023 strategic targets for sustainable, profitable growthDespite the ongoing COVID-19 pandemic, Sika has had a dynamic start to the 2021 fiscal year, continuing its growth trajectory in the first quarter with a new sales record of CHF 1,998.6 million. This equates to an increase of 12.6% in local currencies. Sales growth in Swiss francs amounted to 10.2%,...

DYNAMISCHES WACHSTUM – UMSATZREKORD IM ERSTEN QUARTAL –ANHEBUNG DES JAHRESZIELSUmsatzsteigerung von 12.6% in Lokalwährungen Umsatz 1. Quartal von CHF 1’998.6 Millionen (+10.2% in CHF) Negativer Währungseffekt von -2.4% Akquisition von Kreps (Russland), DriTac (USA) und BR Massa (Brasilien) Ausblick Geschäftsjahr 2021Zweistelliges Umsatzwachstum in Lokalwährungen (bisher: Wachstum in Lokalwährungen von 6%–8%) Überproportionale EBIT-Steigerung, EBIT-Marge soll erstmals auf 15% ansteigenBestätigung der strategischen Ziele 2023 für nachhaltiges, profitables WachstumTrotz der anhaltenden COVID-19-Pandemie ist Sika mit einem dynamischen Jahresauftakt ins Geschäftsjahr 2021 gestartet und setzte den Wachstumskurs im ersten Quartal mit einem neuen Umsatzrekord von CHF 1’998.6 Millionen fort. Dies entspricht einer Steigerung von...